-
EP4479433
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP4479433
| EP4479433 - ANTI-ASGR1 POLYPEPTIDES AND METHODS OF USE FOR IMMUNE TOLERANCE [Right-click to bookmark this link] | Status | Request for examination was made Status updated on 22.11.2024 Database last updated on 10.03.2026 | |
| Former | The international publication has been made Status updated on 25.08.2023 | Most recent event Tooltip | 06.02.2026 | Change - classification | published on 11.03.2026 [2026/11] | 06.02.2026 | Change - classification | published on 11.03.2026 [2026/11] | Applicant(s) | For all designated states Anokion SA EPFL Innovation Park-L Chemin de la Dent D'Oche 1A 1024 Ecublens / CH | [2024/52] | Inventor(s) | 01 /
KONTOS, Stephan 1024 Ecublens / CH | 02 /
CONLEY, Gregory Paul 1024 Ecublens / CH | 03 /
WASSAF, Dina Sami 1024 Ecublens / CH | 04 /
GOLDSTEIN, Rebecca Ilene 1024 Ecublens / CH | 05 /
SILVERMAN, Julie Michelle 1024 Ecublens / CH | 06 /
NIELSON, Nels Peter, II Lebanon, New Hampshire 03766 / US | 07 /
PAULI, Noel Thomas Lebanon, New Hampshire 03766 / US | [2024/52] | Representative(s) | Zwicker, Jörk ZSP Patentanwälte PartG mbB Hansastraße 32 80686 München / DE | [2024/52] | Application number, filing date | 23757098.1 | 16.02.2023 | [2024/52] | WO2023US62761 | Priority number, date | US202263268183P | 17.02.2022 Original published format: US 202263268183 P | US202263268190P | 17.02.2022 Original published format: US 202263268190 P | US202363483456P | 06.02.2023 Original published format: US 202363483456 P | US202363483466P | 06.02.2023 Original published format: US 202363483466 P | [2024/52] | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | WO2023159140 | Date: | 24.08.2023 | Language: | EN | [2023/34] | Type: | A2 Application without search report | No.: | EP4479433 | Date: | 25.12.2024 | Language: | EN | The application published by WIPO in one of the EPO official languages on 24.08.2023 takes the place of the publication of the European patent application. | [2024/52] | Search report(s) | International search report - published on: | US | 07.12.2023 | Classification | IPC: | C07K16/28, A61K47/68 | [2024/52] | CPC: |
C07K16/2851 (EP,IL,KR,US);
A61K39/0008 (EP,IL,KR,US);
A61K39/001 (US);
A61K39/35 (US);
A61K39/385 (US);
A61P3/10 (US);
A61P37/04 (US);
A61P37/06 (EP,IL,KR);
C07K14/7056 (EP,IL,KR);
A61K2039/577 (EP,IL,KR);
A61K2039/6056 (EP,IL,KR,US);
C07K2317/21 (EP,IL,KR);
C07K2317/52 (US);
C07K2317/565 (US);
C07K2317/92 (EP,IL,KR);
C07K2319/00 (EP,IL,KR)
(-)
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, ME, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2024/52] | Title | German: | ANTI-ASGR1-POLYPEPTIDE UND VERFAHREN ZUR VERWENDUNG FÜR IMMUNTOLERANZ | [2024/52] | English: | ANTI-ASGR1 POLYPEPTIDES AND METHODS OF USE FOR IMMUNE TOLERANCE | [2024/52] | French: | POLYPEPTIDES ANTI-ASGR1 ET MÉTHODES D'UTILISATION POUR TOLÉRANCE IMMUNITAIRE | [2024/52] | Entry into regional phase | 06.09.2024 | National basic fee paid | 06.09.2024 | Search fee paid | 06.09.2024 | Designation fee(s) paid | 06.09.2024 | Examination fee paid | Examination procedure | 06.09.2024 | Examination requested [2024/52] | 03.06.2025 | Amendment by applicant (claims and/or description) | Request for further processing for: | 03.06.2025 | Request for further processing filed | 03.06.2025 | Full payment received (date of receipt of payment) Request granted | 12.06.2025 | Decision despatched | The application was refused due to failure to file the sequence listing | 03.06.2025 | Request for further processing filed | 03.06.2025 | Full payment received (date of receipt of payment) Request granted | 12.06.2025 | Decision despatched | Fees paid | Renewal fee | 04.02.2025 | Renewal fee patent year 03 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [DI] US10358497 (NIOI PAUL et al.) [DI] 1-4 * throughout, e.g. col. 1-9 * | [DI] US9771427 (HOFER THOMAS et al.) [DI] 1-4 * throughout, e.g. col. 2-5, claims * | [I] WO2014210540 (BAYLOR RES INST et al.) [I] 1-15 * throughout, e.g. [0002], [0005], [0006], [0016]-[0020], Example 1, 2, claims * | [I] AU2012245170 (BAYLOR RES INST et al.) [I] 1-15 * pg. 15 * | [I] WO2015175957 (BAYLOR RES INST et al.) [I] 1-15 * throughout, par. [0289]-[0295], claim 40 * | [I] FOVET CLAIRE-MALLE ET AL: "Intradermal vaccination prevents anti-MOG autoimmune encephalomyelitis in macaques", EBIOMEDICINE, vol. 47, 1 September 2019 (2019-09-01), NL, pages 492 - 505, XP093032390, ISSN: 2352-3964, DOI: 10.1016/j.ebiom.2019.08.052 [I] 1-15 * Abstract, Sect. 3 * DOI: http://dx.doi.org/10.1016/j.ebiom.2019.08.052 | [I] DAPENG LI ET AL: "Targeting self- and foreign antigens to dendritic cells via DC-ASGPR generates IL-10?producing suppressive CD4 + T cells", THE JOURNAL OF EXPERIMENTAL MEDICINE, vol. 209, no. 1, 2 January 2012 (2012-01-02), United States, pages 109 - 121, XP055451503, ISSN: 0022-1007, DOI: 10.1084/jem.20110399 [I] 1-15 * abstract, pg. 118 right col. * DOI: http://dx.doi.org/10.1084/jem.20110399 | International search | [Y] WO2019215590 (ANOKION SA et al.) [Y] 33-36 * para [00117], claim 13. * | [YA] WO2022006327 (SILVERBACK THERAPEUTICS INC et al.) [Y] 33-36 * claim 1. *[A] 1-21, 84-87 | [YA] US2016304862 (IGAWA TOMOYUKI et al.) [Y] 33-36 * SEQ ID NO: 38 *[A] 1-21 | [Y] US2017240631 (MONROE KATE et al.) [Y] 35, 36 * SEQ ID NO: 289 * | [A] US2016296609 (OH SANGKON et al.) [A] 1-21, 33-36 * para [0012], claims 1, 2, 5 * | [A] US2017088620 (NIOI PAUL et al.) [A] 84-87 * SEQ ID NO: 32539 * | [A] US2020376034 (CHANG GREGORY P et al.) [A] 84-87 * SEQ ID NO: 287 * |